United States v. Ihediwa, No. 22-2247 (7th Cir. 2023)
Annotate this Case
After a high school student died from a fentanyl overdose, Kenosha police investigated the source of the fatal drugs. That investigation led them to Uzorma Ihediwa, who had sold Percocet pills to the student’s neighbor. Police soon discovered that Ihediwa’s pills were not authentic Percocet but were counterfeits that contained a mixture of drugs, including fentanyl. Ihediwa pleaded guilty to one count of distributing fentanyl, 21 U.S.C. 841(a)(1). The only contested issue at sentencing was whether Ihediwa knew that the pills contained fentanyl. If so, then his Sentencing Guidelines offense level would be raised by four levels. U.S.S.G. 2D1.1(b)(13) applies “[i]f the defendant knowingly misrepresented or knowingly marketed as another substance a mixture or substance containing fentanyl.” Ihediwa urged that he did not manufacture the pills, did not know that they were counterfeit, and did not know that they contained fentanyl. The district court applied the enhancement.
The Seventh Circuit affirmed Ihediwa’s 40-month sentence. Because the district court emphasized that its ultimate sentencing decision was not affected by the Guidelines dispute, any error in its interpretation of the Guidelines was harmless. This sentence was below the Guidelines range, whether with the enhancement (78–97 months) or without it (51–63 months).
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.